<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20171007036615N16</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-11-18</date_registration>
      <primary_sponsor>Tabriz University of Medical Sciences</primary_sponsor>
      <public_title>Design and evaluation of an educational web application based on woman-centered care for childbirth preparation</public_title>
      <acronym></acronym>
      <scientific_title>Design, development and evaluation of an educational web application based on woman-centered care for childbirth preparation in pregnant women</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2027-01-11</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>70</target_size>
      <recruitment_status>Pending</recruitment_status>
      <url>https://irct.ir/trial/86456</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: One-half of the health centers will be selected, considering diverse geographical locations and socioeconomic levels. In total, five centers will be selected from different areas of Karaj (taking into account diversity in terms of socioeconomic status). A list of pregnant mothers is available in the 'Sib' Health Information System at the health centers. The researcher will attend the selected centers, prepare a list of potentially eligible individuals, and then contact them by phone. After assessing the inclusion and exclusion criteria, those who qualify will be given a brief explanation of the study's purpose. If they are willing to participate, they will be invited to an in-person session at a health center near their residence.

Participants will be allocated to either the intervention or control group with a 1:1 ratio using block randomization, stratified by the number of previous births. A person not involved in the sampling will perform the allocation using RAS software with block sizes of 4 and 6.

The allocation details will be written on paper and placed in sequentially numbered, opaque, sealed envelopes to ensure allocation concealment. The envelopes will be opened in the order of the participants' entry into the study. The mother's name will be written on the selected envelope, and she will be informed of her assigned group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: childbirth preparation. Condition 2: fear of childbirth.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The designed web application will be installed on the smartphones of participants in the intervention group. Its content will be personalized so that, at the beginning, users must enter information such as gestational age and their symptoms. Based on these settings, each user will access the section of the app that contains information relevant to their pregnancy condition. The researcher will train participants in the intervention group on how to use the app so they can fully utilize its content over four weeks. The researcher will also provide online support and guidance during this period. Throughout the intervention, the researcher (student) will maintain contact with participants via phone calls and text messages to remind them to use the relevant content at each stage, and will share their contact information for any questions. To ensure thorough engagement with the app content, a limited set of relevant questions will be designed to be answered before and after each section. Intervention 2: Control group: They will receive routine care according to the national guidelines.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is No further information is available.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr.Esmat Mehrabi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>South Shariati Street</address>
        <city>tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5138947977</zip>
        <telephone>+98 41 3479 6770</telephone>
        <email>b.mehrabi@yahoo.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Esmat Mehrabi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>South Shariati Street</address>
        <city>tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5138947977</zip>
        <telephone>+98 41 3479 6770</telephone>
        <email>b.mehrabi@yahoo.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Gestational age of 24 to 32 weeks
Singleton pregnancy
Literacy (ability to read and write)
Ability to use a mobile application
Not having a medical field education
Possession of a smartphone</inclusion_criteria>
      <agemin>15 years</agemin>
      <agemax>49 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Development of any pregnancy complications, such as preeclampsia.
Bleeding and intrauterine fetal death.
Multiple pregnancy
Presence of chronic diseases or conditions that are induced or exacerbated by pregnancy, such as hypertension, cardiovascular diseases, diabetes, preeclampsia, etc.
Indications for cesarean section, such as placenta previa, non-cephalic presentations, abnormal fetal heart rate patterns, etc.
History of cesarean section or uterine surgery/scarring.
Previous participation in physiological childbirth classes.
Abnormal pregnancy conditions, such as polyhydramnios, oligohydramnios, or intrauterine growth restriction (IUGR).</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The designed web application will be installed on the smartphones of participants in the intervention group. Its content will be personalized so that, at the beginning, users must enter information such as gestational age and their symptoms. Based on these settings, each user will access the section of the app that contains information relevant to their pregnancy condition. The researcher will train participants in the intervention group on how to use the app so they can fully utilize its content over four weeks. The researcher will also provide online support and guidance during this period. Throughout the intervention, the researcher (student) will maintain contact with participants via phone calls and text messages to remind them to use the relevant content at each stage, and will share their contact information for any questions. To ensure thorough engagement with the app content, a limited set of relevant questions will be designed to be answered before and after each section.</i_keyword>
      <i_keyword>Control group: They will receive routine care according to the national guidelines.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Childbirth preparation score. Timepoint: Before the intervention and 4 weeks after the intervention. Method of measurement: Childbirth Readiness Scale(CRS).</prim_outcome>
      <prim_outcome>Fear of childbirth score. Timepoint: Before the intervention and 4 weeks after the intervention and 24 hours after delivery. Method of measurement: Wijma delivery expectancy/experience questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Childbirth experience score. Timepoint: 24hours after delivery. Method of measurement: Childbirth Experiences  (CEQ-2.0) 2.0 Questionnaire version.</sec_outcome>
      <sec_outcome>Child Birth Self Efficacy score. Timepoint: Before the intervention and 24 hours after delivery. Method of measurement: Child Birth Self Efficacy questionnaire.</sec_outcome>
      <sec_outcome>Postpartum depression literacy score. Timepoint: Before the intervention and 4 weeks after the intervent. Method of measurement: Postpartum depression literacy Scale (PoDLiS).</sec_outcome>
      <sec_outcome>Frequency of mode of delivery. Timepoint: 24 hours after delivery. Method of measurement: Frequency of mode of delivery check list.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tabriz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-09-08</approval_date>
        <contact_name>Research Ethics Committees of Tabriz University of Medical Science</contact_name>
        <contact_address>South Shariati Street, Faculty of Nursing and Midwifery, Tabriz tabriz East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
